Global Urinary Tract Infection Market
As the global economy mends, the 2021 growth of Urinary Tract Infection (UTI) will have significa ... Read More
As the global economy mends, the 2021 growth of Rapid Medical Diagnostic Devices will have significant change from previous year. According to our (LP Information) latest study, the global Rapid Medical Diagnostic Devices market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Rapid Medical Diagnostic Devices market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Rapid Medical Diagnostic Devices market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Rapid Medical Diagnostic Devices market, reaching US$ million by the year 2028. As for the Europe Rapid Medical Diagnostic Devices landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Rapid Medical Diagnostic Devices players cover Danaher Corporation, Abbott Laboratories, Acon Laboratories, and Roche, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Rapid Medical Diagnostic Devices market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Lateral Flow
Agglutination Assays
Flow-Through
Biosensors
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Cardio Metabolic Testing
Infectious Disease Testing
Nephrology Testing
Drugs of Abuse (DoA) Testing
Blood Glucose Testing
Pregnancy Testing
Cancer Biomarker Testing
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Danaher Corporation
Abbott Laboratories
Acon Laboratories
Roche
BD
Johnson & Johnson
Trinity Biotech Plc
Siemens Healthineers
GE
As the global economy mends, the 2021 growth of Urinary Tract Infection (UTI) will have significa ... Read More
As the global economy mends, the 2021 growth of Cystitis will have significant change from previo ... Read More
As the global economy mends, the 2021 growth of Glass Cement will have significant change from pr ... Read More
As the global economy mends, the 2021 growth of Gastrointestinal Bleeding Therapeutic Devices wil ... Read More